Outlook Therapeutics
OTLK
#8585
Rank
ยฃ96.6 M
Marketcap
ยฃ4.08
Share price
-2.84%
Change (1 day)
-40.43%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -ยฃ74.85 Million

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ41 Million, an increase over its 2022 earnings that were of -ยฃ55.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ74.85 Million82.56%
2023 -ยฃ41 Million-26.7%
2022 -ยฃ55.93 Million32.13%
2021 -ยฃ42.33 Million46.21%
2020 -ยฃ28.95 Million-18.82%
2019 -ยฃ35.67 Million16.62%
2018 -ยฃ30.58 Million57.88%
2017 -ยฃ19.37 Million-56.17%
2016 -ยฃ44.19 Million-9.26%
2015 -ยฃ48.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ91.12 Million 21.71% Jersey
-ยฃ0.22 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ11.14 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ58.17 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK